Forum

kc4310
@kc4310
Eminent Member
Joined: Mar 5, 2021
Last seen: Jun 20, 2021
Topics: 0 / Replies: 31
Reply
RE: Factors Contributing to Risk Values

I too agree with the comments above. The probability of occurrence and the severity of the risk drive the risk values. The occurrence can be frequen...

3 years ago
Reply
RE: What is risk control? What are some examples of risk control measures taken?

Changing design may be cost prohibitive , but sometimes it has to be done, even if it cause financial stress for a company. The alternative is neglig...

3 years ago
Reply
RE: Risk Management Tools

My time tested risk management tool has been brainstorming with a SWOT analysis mind-set. The ability to approach brainstorming honestly and to empat...

3 years ago
Reply
RE: Risk Management Tools

My time tested risk management tool has been brainstorming with a SWOT analysis mind-set. The ability to approach brainstorming honestly and to empat...

3 years ago
Reply
RE: Ethical Issues with Clinical Trials

Your question has a lot of depth. As accepting clinical trials “as is” is easy because they have always been done a certain way. It is easy to also ...

3 years ago
Reply
RE: Informed consent: What if Henrietta Lacks checked No for research use?

@alexandrabuga Great topic, a nice contrast to typical posts. I do believe that Henretta lics heirs were ultimately compensated – largely due the pub...

3 years ago
Reply
RE: WHAT IS THE OBJECTIVE OF CLINICAL TESTING ON PHARMACEUTICA DRUGS?

@amd29, I think you're suggesting the multi-billion dollar pharmaceutical industry has little value? Which I would like to agree, but there is strong...

3 years ago
Reply
RE: Partnership characteristics

Yes, I will consider having a partner. Having a partner can be a great thing. Therefore, you must consider what you're will to trade off. It is ver...

3 years ago
Forum
Reply
RE: S-Corp vs C-Corp

Medtronic and Boston Scientific are c-corps because they are publicly traded companies with thousands of shareholders. S-corps are really tough to gi...

3 years ago
Forum
Reply
RE: 510K is Nonsense

The merit is very limited, and you actually make a really good point. At a minimum, there should be a "time-out" period where comparison to products ...

3 years ago
Reply
RE: Issues with the Quality Department

I think the quality department can become to preoccupied with finding problems, which is not hard to do for any product. Therefore, a collaborative e...

3 years ago
Reply
RE: Perception of QA/QC

On occasion, I passively thought the two roles were the same. Until I had opportunity to do QC. There is a clear delineation between the two. QA se...

3 years ago
Reply
RE: Discussion Topic: Biomaterial Selection

If you select polymers then you will certainly need implantation, genotoxicity, system toxicity, irritation, sensitization, and cytotoxicity test. Te...

3 years ago
Reply
RE: Research for the Fututre or Now?

Both leave a legacy, but I tend to agree that I rather see the impact now. Still, who's to say that my research activity will not foster future resea...

3 years ago
Reply
RE: Academia vs. Industry Research

@merzkrashed great feedback. Are you a product manager? Some years ago I had the unfortunate experience of being apart of a product launch that was ...

3 years ago
Page 1 / 3